Sectoral Asset Management Inc Eli Lilly & CO Transaction History

Sectoral Asset Management Inc

$88.5 Million
Q1 2025

A detailed history of Sectoral Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Sectoral Asset Management Inc holds 9,416 shares of LLY stock, worth $7.18 Million. This represents 8.79% of its overall portfolio holdings.

Number of Shares

9,416

Previous 12,546 24.95%

Holding current value

$7.18 Million

Previous $9.69 Million 19.71%

% of portfolio

8.79%

Previous 9.71%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$725.72 - $929.72 $2.27 Million - $2.91 Million	-3,130 Reduced 24.95%	9,416 $7.78 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $1.13 Million - $1.44 Million	1,550 Added 14.1%	12,546 $9.69 Million
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $9.59 Million - $11.9 Million	-12,419 Reduced 53.04%	10,996 $9.74 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $1.63 Million - $2.05 Million	-2,250 Reduced 8.77%	23,415 $21.2 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $532,980 - $713,052	-900 Reduced 3.39%	25,665 $20 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.73 Million - $2.04 Million	3,300 Added 14.18%	26,565 $15.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $217,350 - $299,650	-500 Reduced 2.1%	23,265 $12.5 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $1.66 Million - $1.95 Million	5,350 Added 29.05%	23,765 $8.16 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $2.8 Million - $3.29 Million	-10,050 Reduced 35.31%	18,415 $5.97 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $234,690 - $291,660	-1,000 Reduced 3.39%	28,465 $8.15 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $2.53 Million - $3.14 Million	-11,250 Reduced 27.63%	29,465 $8.14 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $819,920 - $1.01 Million	3,700 Added 10.0%	40,715 $9.41 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $1.75 Million - $2.27 Million	-9,700 Reduced 20.76%	37,015 $8.5 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $796,952 - $1.03 Million	-4,850 Reduced 9.41%	46,715 $8.73 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $3.03 Million - $3.51 Million	20,750 Added 67.34%	51,565 $7.63 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $613,890 - $738,810	-4,500 Reduced 12.74%	30,815 $5.06 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $3.63 Million - $4.49 Million	-30,450 Reduced 46.3%	35,315 $4.9 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $1.07 Million - $1.32 Million	10,000 Added 17.93%	65,765 $8.64 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $5.44 Million - $5.91 Million	-50,900 Reduced 47.72%	55,765 $6.24 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $531,792 - $620,736	-4,800 Reduced 4.31%	106,665 $11.8 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $812,451 - $956,314	7,299 Added 7.01%	111,465 $14.5 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $5.13 Million - $5.74 Million	48,400 Added 86.79%	104,166 $12.1 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $5.74 Million - $7.17 Million	-66,834 Reduced 54.51%	55,766 $5.98 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $4.5 Million - $5.17 Million	-59,500 Reduced 32.67%	122,600 $10.5 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $1.33 Million - $1.57 Million	17,900 Added 10.9%	182,100 $14.1 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $13.5 Million - $14.4 Million	164,200	164,200 $13.9 Million

Others Institutions Holding LLY

# of Institutions

4,394

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $725B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Eli Lilly & CO Transaction History